changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Building on the established clinical performance of LC Bead®, LC Bead LUMI™ comprises a radiopaque moiety1, allowing for a more precisely controlled procedure and the opportunity to revolutionize the treatment of hypervascular tumors and arteriovenous malformations (AVMs).
LC Bead LUMI™ is a next-generation development of LC Bead® that provides every time:1
Real-time visible confirmation of bead location during embolization.
The potential to provide increased control by enabling real-time adjustments and enhanced determination of embolization endpoints, therefore optimized patient treatment.
Demonstrate treatment success to your patients, tumor board and inform decisions for future management.
With LC Bead LUMI™, you are empowered to see the bead during and after treatment.
During LUMI embolization — see precisely where LC Bead LUMI™ need to be delivered1.
After LUMI embolization — with lasting radiopacity, LC Bead LUMI™ continues to be visible in follow-up scans1.
LC Bead LUMI™ offers you a new level of control with real-time feedback both during and after embolisation.
LC Bead LUMI™ is designed to offer a more precise and controlled procedure than current techniques.
LC Bead LUMI™ enables real-time adjustment during the whole procedure1.
LC Bead LUMI™ offers the best opportunity to individualize your patients’ treatment.
LC Bead LUMI™ offers the precision and control you need to:
The radiopacity of LC Bead LUMI™ is equivalent to commonly used contrast agents1 — no special calibration of equipment is needed.
LC Bead LUMI™ are intended to be used for the embolization of hypervascular tumors and arteriovenous malformations (AVMs).
*Images courtesy NIH with permission. Any reference to NIH or the authors should not be viewed as an endorsement of BTG, its products or services.
1. Duran R, et al. Theranostics 2016;6:28–38.